Personalized care may hold the key as survival in advanced endometrial cancer remains poor regardless of surgery type or ...

The cancer often silent in its early stages, is now increasingly affecting women under 50, including those in their early 30s ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

Women with preeclampsia in their first pregnancy had a lower risk of developing breast, cervical, and lung cancer later in ...

Uterine cancer is the most common gynecologic cancer in the U.S. In 2024, there were almost 70,000 cases, ... Elkin pointed to decreases in hysterectomies -- surgery to remove the uterus ...